Patent intelligence · US
US 10179155
Phosphodiesterase-4 inhibiting phytochemical compositions
Phosphodiesterase-4 inhibiting phytochemical compositions
Patent details — US 10179155
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 15, 2019
- Expiration
- Jan 10, 2039
- Applicant
- Nature's Sunshine Products, Inc.
- Claims
- 14
- CPC classes
- A61K, A61K31/198, A61K31/51, A61K31/555
Quick answer
US 10179155 (Phosphodiesterase-4 inhibiting phytochemical compositions) is held by Nature's Sunshine Products, Inc.. Status: granted. Granted Jan 15, 2019. Expires Jan 10, 2039 (13 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Nature's Sunshine Products, Inc.
- Grant date
- Expiration
- Claims
- 14
- CPC classes
- A61K, A61K31/198, A61K31/51, A61K31/555, A61K31/717, A61K33/06
More from Nature's Sunshine Products, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12428432
Thienopyrimidine derivatives having stereo configurations and use thereof in medicine
granted -
US 12428389
Diarylamide compound and application thereof
granted -
US 12384853
Anti-HER2/PD1 bispecific antibody
granted -
US 12324812
Glucopyranosyl derivatives and their uses
granted -
US 12319748
Antibody binding to human HER2 and preparation method and use thereof
granted -
US 12312348
RET inhibitors, pharmaceutical compositions and uses thereof
granted -
US 12269886
Tetravalent bispecific antibody against PD-1 and PD-L1
granted -
US 12258317
Isoquinolinone compound for inhibiting ssao/vap-1, and use thereof
granted
Frequently asked questions
What is US patent 10179155?
US 10179155 (Phosphodiesterase-4 inhibiting phytochemical compositions) is held by Nature's Sunshine Products, Inc.. Status: granted. Granted Jan 15, 2019. Expires Jan 10, 2039 (13 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10179155?
Nature's Sunshine Products, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 121 pharmaceutical patents for this assignee.
When does US 10179155 expire?
Our index shows an expiration date of Jan 10, 2039 (13 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.